MM
Mary K Moreland (EXECUTIVE VICE PRESIDENT) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Abbott Laboratories (ABT). The largest single filing was $406K of ABT (3,500 sh × $116.00, as filed), executed Nov 5. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$406K
shares × price, as filed
Last traded
Nov 5
Filed Nov 6
Median ADV $1.4B across their filed names
Open performance→Volume by month
Buys $0
Sells $515K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
ABTRecent filings
ABTSALE
Abbott Laboratories
View filing →
$406K3,500 sh × $116.00
Exec Nov 5
Filed Nov 6 · 5:09 PM ET ABTSALE Abbott Laboratories View filing → $109K
791 sh × $138.17
Exec Mar 3 2025
Filed Mar 4 2025 · 5:30 PM ET